R. Vickery - Concepedia

Author

R. Vickery

Also Known As

R G Vickery, R G. Vickery, R Vickery, R. G. Vickery, R. VICKERY, R. Vickery, R.G. Vickery, R. G. Vickery, Ron Vickery, Ross G. Vickery

Publications

606

Citations

H-Index

Concepts

All Affiliations

Theravance Biopharma (United States)

About

R. Vickery is an author at Theravance Biopharma (United States) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	244
2	Social Sciences	3	3	98
3	Biochemistry	2	2	57
4	Health Sciences	1	1	34
5	Anesthesia	1	1	23

R. Vickery

Publications

574

Citations

H-Index

Page 1

	Year	Citations
Anesthetic and Hemodynamic Effects of the Stereoisomers of Medetomidine, an ??2-Adrenergic Agonist, in Halothane-Anesthetized Dogs R. Vickery, Brett C. Sheridan, Ira S. Segal, Anesthesia & Analgesia	1988	144
The 5‐HT<sub>4</sub> receptor agonist, tegaserod, is a potent 5‐HT<sub>2B</sub> receptor antagonist <i>in vitro</i> and <i>in vivo</i> David T. Beattie, Jacqueline A.M. Smith, Daniel G. Marquess, British Journal of Pharmacology	2004	119
The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity Jacqueline A.M. Smith, David T. Beattie, Daniel G. Marquess, Naunyn-Schmiedeberg s Archives of Pharmacology Signal TransductionFunctional SelectivityMedicinePhysiologyMechanism Of Action	2008	58
Molecular identification of SqKv1A. A candidate for the delayed rectifier K channel in squid giant axon. Joshua J. C. Rosenthal, R. Vickery, W. F. Gilly The Journal of General Physiology Ms. OocytesMolecular BiologyNeurotransmissionCellular NeurobiologyRectifier K Channel	1996	41
The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone David T. Beattie, Madhavi Cheruvu, Ngoc Mai, Naunyn-Schmiedeberg s Archives of Pharmacology Adl 08-0011Molecular PharmacologyAddictionPharmacologyNeuropharmacology	2007	34
Comparison of the Pharmacological Properties of Rat Na<sub>V</sub>1.8 with Rat Na<sub>V</sub>1.2a and Human Na<sub>V</sub>1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPR<sup>R</sup> R. Vickery, Shanti M. Amagasu, Ray Chang, Receptors and Channels Synaptic TransmissionPlate ReaderExperimental PharmacologyCellular PhysiologySocial Sciences	2004	33
An in vitro investigation of the cardiovascular effects of the 5-HT4 receptor selective agonists, velusetrag and TD-8954 David T. Beattie, Deborah L. Higgins, Mike Ero, Vascular Pharmacology HypertensionCardiovascular DiseaseMedicinePhysiologyCardiovascular Pharmacology	2012	31
Comparison of the Pharmacological Properties of Rat NaV1.8 with Rat NaV1.2a and Human NaV1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPRR R. Vickery, Shanti M. Amagasu, Ray Chang, Receptors and Channels Synaptic TransmissionNeurotransmitterAnesthetic MechanismPlate ReaderExperimental Pharmacology	2004	24
Action of the stereoisomers of medetomidine, in halothane-anesthetized dogs. R. Vickery, Mervyn Maze PubMed Halothane-anesthetized DogsMedicineVeterinary ScienceAnesthesia PracticeDl-medetomidine Administration	1989	23
Evidence for a Multivalent Interaction of Symmetrical, N-Linked, Lidocaine Dimers with Voltage-Gated Na+ Channels Jacqueline A.M. Smith, Shanti M. Amagasu, J. Hembrador, Molecular Pharmacology	2005	19

Page 1